Version 5.4
Bos taurus Protein: CRISPLD2
Summary
InnateDB Protein IDBP-681461.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol CRISPLD2
Protein Name Cysteine-rich secretory protein LCCL domain-containing 2
Synonyms
Species Bos taurus
Ensembl Protein ENSBTAP00000028221
InnateDB Gene IDBG-630027 (CRISPLD2)
Protein Structure
UniProt Annotation
Function Promotes matrix assembly. {ECO:0000250}.
Subcellular Localization Secreted {ECO:0000250}.
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 1 interaction(s) predicted by orthology.
Predicted by orthology
Total 1 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0005539 glycosaminoglycan binding
GO:0008201 heparin binding
Biological Process
GO:0030198 extracellular matrix organization
GO:0060325 face morphogenesis
Cellular Component
GO:0005576 extracellular region
GO:0030133 transport vesicle
GO:0031012 extracellular matrix
Protein Structure and Domains
PDB ID
InterPro IPR001283 Cysteine-rich secretory protein, allergen V5/Tpx-1-related
IPR004043 LCCL domain
IPR014044 CAP domain
PFAM PF03815
PF00188
PRINTS PR00837
PIRSF PIRSF038921
SMART SM00603
SM00198
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt A6QLZ7
PhosphoSite PhosphoSite-
TrEMBL D1Z306
UniProt Splice Variant
Entrez Gene 505329
UniGene Bt.55503
RefSeq NP_001093769
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL AY369781 BC148143
GenPept AAI48144 AAR14258

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca